Knockout of CLTC gene reduces but not completely block SFTSV infection

Tiezhu Liu1, Jiajia Li2, Xueqi Wang3

  • 1National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

Plos One
|August 25, 2023
PubMed

Insights

SFTSV can still infect cells even without clathrin heavy chains (CLTC). Lipid raft-mediated endocytosis acts as a clathrin-independent pathway for SFTSV entry, alongside clathrin-dependent mechanisms.

Area of Science:

  • Virology
  • Cell Biology
  • Molecular Biology

Background:

  • Clathrin is crucial for viral entry into host cells.
  • Previous studies partially inhibited clathrin function, leaving the role of complete clathrin absence in SFTSV infection unclear.

Purpose of the Study:

  • To investigate SFTSV entry mechanisms in the absence of clathrin.
  • To establish a clathrin-heavy-chain (CLTC) knockout cell line for studying clathrin function.
  • To identify alternative viral entry pathways for SFTSV.

Main Methods:

  • CRISPR/Cas9 technology was used to create a CLTC knockout A549 cell line.
  • PCR, Western blot, immunofluorescence, and T7E1 analysis verified CLTC knockout.
  • Off-target effects were assessed using PCR and Sanger sequencing.
  • SFTSV infection assays were performed with and without CLTC, using lipid raft and macropinocytosis inhibitors.

Main Results:

  • SFTSV infection was significantly reduced, but not abolished, in CLTC knockout cells.
  • Lipid raft inhibitor Filipin, but not macropinocytosis inhibitor EIPA, reduced SFTSV infection.
  • The inhibitory effect of Filipin was more pronounced in CLTC knockout cells.
  • This suggests both clathrin-dependent and lipid raft-mediated endocytosis are major SFTSV entry routes.

Conclusions:

  • A CLTC knockout cell line was successfully generated, providing a novel model for clathrin function studies.
  • SFTSV can infect cells independently of clathrin, utilizing lipid raft-mediated endocytosis as a key alternative pathway.